We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals
ANIP

72 hedge funds and large institutions have $128M invested in ANI Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less funds holding

Funds holding: 81 → 72 (-9)

18% less capital invested

Capital invested by funds: $156M → $128M (-$27.8M)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
72
Holders Change
-9
Holders Change %
-11.11%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
32
Reduced
20
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CCM
Consonance Capital Management
New York
+$5.83M
2
HVC
Healthcare Value Capital
New Jersey
+$4.53M
3
Wells Fargo
Wells Fargo
California
+$3.06M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$2.83M
5
TI
Turner Investments
Pennsylvania
+$2.27M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$7.79M
2
LOAMU
Lombard Odier Asset Management (USA)
New York
-$5.17M
3
EI
EAM Investors
California
-$3.03M
4
Morgan Stanley
Morgan Stanley
New York
-$3.01M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$863K +$90K +3,003 +11%
Renaissance Technologies
27
Renaissance Technologies
New York
$803K -$2.68M -89,300 -76%
Morgan Stanley
28
Morgan Stanley
New York
$791K -$3.01M -100,276 -78%
Ameriprise
29
Ameriprise
Minnesota
$696K +$379K +12,655 +106%
ARTA
30
A.R.T. Advisors
New York
$680K +$319K +10,629 +79%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$678K – – –
BCM
32
Bridgeway Capital Management
Texas
$666K – – –
CCMH
33
Cornerstone Capital Management Holdings
New York
$651K +$689K +23,000 New
BIM
34
BlackRock Investment Management
Delaware
$566K +$7.01K +234 +1%
Millennium Management
35
Millennium Management
New York
$528K -$7.79M -259,820 -93%
SO
36
STRS Ohio
Ohio
$458K +$417K +13,900 +604%
PP
37
PDT Partners
New York
$447K +$95.9K +3,200 +25%
CS
38
Credit Suisse
Switzerland
$403K -$744K -24,828 -64%
Jane Street
39
Jane Street
New York
$399K -$616K -20,541 -59%
PPA
40
Parametric Portfolio Associates
Washington
$394K +$50.6K +1,687 +14%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$358K +$2.16K +72 +0.6%
VKH
42
Virtu KCG Holdings
New York
$315K +$38.2K +1,276 +13%
Citadel Advisors
43
Citadel Advisors
Florida
$307K -$195K -6,500 -37%
Charles Schwab
44
Charles Schwab
California
$286K – – –
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$270K – – –
TA
46
Teachers Advisors
New York
$270K – – –
AL
47
Airain Ltd
Guernsey
$269K +$103K +3,452 +57%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$224K – – –
PCM
49
Prelude Capital Management
New York
$218K +$190K +6,351 +471%
NFA
50
Nationwide Fund Advisors
Ohio
$149K -$120 -4 -0.1%
1
2
3 4

ANIP Hedge Fund Activity: Q3 2014 in Review

72 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q3 2014, worth a combined $128M — down 18% from $156M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ANIP and 6 opened new positions — a net loss of 9 holders — while 20 trimmed existing stakes and 32 added.

The largest buyer was Consonance Capital Management, adding an estimated $5.83M. The largest seller was Millennium Management, cutting an estimated $7.79M.

  • 72 institutional investors held ANI Pharmaceuticals (ANIP) as of Q3 2014, down from 81 in Q2 2014.
  • Funds reported $128M of ANI Pharmaceuticals stock for Q3 2014, down 18% quarter-over-quarter.
  • 6 funds opened new ANI Pharmaceuticals positions in Q3 2014 and 15 closed out, a net change of -9 holders.
  • The largest ANI Pharmaceuticals buyer in Q3 2014 was Consonance Capital Management, an estimated $5.83M added.
  • The largest ANI Pharmaceuticals seller in Q3 2014 was Millennium Management, an estimated $7.79M sold.

Based on aggregated 13F filings for Q3 2014.